Gagnon Marie-Pierre, Candas Bernard, Desmartis Marie, Gagnon Johanne, La Roche Daniel, Rhainds Marc, Coulombe Martin, Dipankui Mylène Tantchou, Légaré France
Research Centre of the CHU de Québec, Hôpital Saint-François d'Assise, 10 rue de l'Espinay, D6-726, Quebec City, QC G1L 3L5, Canada.
BMC Health Serv Res. 2014 Jun 20;14:273. doi: 10.1186/1472-6963-14-273.
Public and patient involvement in the different stages of the health technology assessment (HTA) process is increasingly encouraged. The selection of topics for assessment, which includes identifying and prioritizing HTA questions, is a constant challenge for HTA agencies because the number of technologies requiring an assessment exceeds the resources available. Public and patient involvement in these early stages of HTA could make assessments more relevant and acceptable to them. Involving them in the development of the assessment plan is also crucial to optimize their influence and impact on HTA research. The project objectives are: 1) setting up interventions to promote patient participation in three stages of the HTA process: identification of HTA topics, prioritization, and development of the assessment plan of the topic prioritized; and 2) assessing the impact of patient participation on the relevance of the topics suggested, the prioritization process, and the assessment plan from the point of view of patients and other groups involved in HTA.
Patients and their representatives living in the catchment area of the HTA Roundtable of Université Laval's Integrated University Health Network (covering six health regions of the Province of Quebec, Canada) will be involved in the following HTA activities: 1) identification of potential HTA topics in the field of cancer; 2) revision of vignettes developed to inform the prioritization of topics; 3) participation in deliberation sessions for prioritizing HTA topics; and 4) development of the assessment plan of the topic prioritized. The research team will coordinate the implementation of these activities and will evaluate the process and outcomes of patient involvement through semi-structured interviews with representatives of the different stakeholder groups, structured observations, and document analysis, mainly involving the comparison of votes and topics suggested by various stakeholder groups.
This project is designed as an integrated approach to knowledge translation and will be conducted through a close collaboration between researchers and knowledge users at all stages of the project. In response to the needs expressed by HTA producers, the knowledge produced will be directly useful in guiding practices regarding patient involvement in the early phases of HTA.
目前越来越鼓励公众和患者参与卫生技术评估(HTA)过程的不同阶段。评估主题的选择,包括确定HTA问题并进行优先级排序,对HTA机构来说始终是一项挑战,因为需要评估的技术数量超过了可用资源。公众和患者参与HTA的这些早期阶段可以使评估对他们而言更具相关性和可接受性。让他们参与评估计划的制定对于优化他们对HTA研究的影响也至关重要。该项目目标如下:1)制定干预措施,以促进患者参与HTA过程的三个阶段:HTA主题的识别、优先级排序以及对优先排序主题的评估计划制定;2)从患者和参与HTA的其他群体的角度,评估患者参与对所建议主题的相关性、优先级排序过程以及评估计划的影响。
居住在拉瓦尔大学综合大学健康网络HTA圆桌会议服务区域(覆盖加拿大魁北克省的六个卫生区域)的患者及其代表将参与以下HTA活动:1)确定癌症领域潜在的HTA主题;2)修订为告知主题优先级排序而编写的案例;3)参与HTA主题优先级排序的审议会议;4)制定优先排序主题的评估计划。研究团队将协调这些活动的实施,并将通过与不同利益相关者群体的代表进行半结构化访谈、结构化观察和文件分析来评估患者参与的过程和结果,主要涉及比较各利益相关者群体的投票和所建议的主题。
该项目被设计为一种知识转化的综合方法,并将在项目的各个阶段通过研究人员与知识使用者之间的密切合作来开展。为响应HTA生产者表达的需求,所产生的知识将直接有助于指导有关患者参与HTA早期阶段的实践。